Jaguar health to present september 7 at emerging growth conference and at the september 11-13 h.c. wainwright annual global investment conference

Napo pharmaceuticals, a jaguar family company, reported completion august 17 of last patient last visit for its pivotal phase 3 ontarget trial of crofelemer for preventive treatment of cancer therapy-related diarrhea san francisco, ca / accesswire / august 28, 2023 / jaguar health, inc. (nasdaq:jagx) today announced that lisa conte, the company's president, founder, and ceo, will present virtually at the emerging growth conference september 7, 2023 and virtually at the september 11-13, 2023 h.c. wainwright 25th annual global investment conference.
JAGX Ratings Summary
JAGX Quant Ranking